Abstract:Schizophrenia is a severe neuropsychiatric disorder with core features including hallucinations, delusions, and cognition deficits. Accumulating evidence has implicated abnormal DNA methylation in the development of schizophrenia. However, the mechanisms by which DNA methylation changes alter the risk for schizophrenia remain largely unknown. We recently carried out a DNA methylome study of peripheral blood samples from 469 first-episode patients with schizophrenia and 476 age- and gender-matched healthy controls of Han Chinese origin. Genomic DNA methylation patterns were quantified using an Illumina Infinium Human MethylationEPIC BeadChip. We identified multiple differentially methylated positions (DMPs) and regions between patients and controls. The most significant DMPs were annotated to genes C17orf53, THAP1 and KCNQ4 (KV7.4), with Bonferroni-adjusted P values of ({mathrm{1}}{mathrm{.34}} imes {mathrm{10}}^{{mathrm{ - 12}}}), ({mathrm{1}}{mathrm{.15}} imes {mathrm{10}}^{{mathrm{ - 11}}}), and ({mathrm{3}}{mathrm{.11}} imes {mathrm{10}}^{{mathrm{ - 11}}}), respectively. In particular, KCNQ4 encodes a voltage-gated potassium channel of the KV7 family, which is linked to neuronal excitability. The genes associated with top-ranked DMPs also included many genes involved in nervous system development, such as LIMK2 and TMOD2. Gene ontology analysis of the differentially methylated genes further identified strong enrichment of neuronal networks, including neuron projection extension, axonogenesis and neuron apoptotic process. Finally, we provided evidence that schizophrenia-associated epigenetic alterations co-localize with genetic susceptibility loci. By focusing on first-episode schizophrenia patients, our investigation lends particularly strong support for an important role of DNA methylation in schizophrenia pathogenesis unconfounded by the effects of long-term antipsychotic medication or disease progression. The observed DNA methylation aberrations in schizophrenia patients could potentially provide a valuable resource for identifying diagnostic biomarkers and developing novel therapeutic targets to benefit schizophrenia patients.

Hyper-Coordinated DNA Methylation is Altered in Schizophrenia and Associated with Brain Function

DNA Methylation in Schizophrenia: Progress and Challenges

Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients

Chromatin Profiling in Human Neurons Reveals Aberrant Roles for Histone Acetylation and BET Family Proteins in Schizophrenia

Schizophrenia is associated with altered DNA methylation variance

Genome-wide DNA methylation analysis of peripheral blood cells derived from patients with first-episode schizophrenia in the Chinese Han population

Methylation Patterns in Whole Blood Correlate with Symptoms in Schizophrenia Patients.

Correlation between DNA methylation and gene expression in the brains of patients with bipolar disorder and schizophrenia.

The association of DNA methylation and brain volume in healthy individuals and schizophrenia patients

An integrated genetic-epigenetic analysis of schizophrenia: evidence for co-localization of genetic associations and differential DNA methylation

DNA Methylation Differences in Cortical Grey and White Matter in Schizophrenia.

Network Modules Linking Expression and Methylation in Prefrontal Cortex of Schizophrenia

Genome-wide analysis of DNA methylation in 106 schizophrenia family trios in Han Chinese

Identification of Schizophrenia-Associated Loci by Combining DNA Methylation and Gene Expression Data from Whole Blood

DNA Methylation Meta-Analysis Reveals Cellular Alterations in Psychosis and Markers of Treatment-Resistant Schizophrenia

DNA Hyper-methylation Associated with Schizophrenia May Lead to Increased Levels of Autoantibodies

DNA Methylation and Schizophrenia: Current Literature and Future Perspective

Genome-wide DNA Methylation Analysis in Families with Multiple Individuals Diagnosed with Schizophrenia and Intellectual Disability.

Cross-Tissue Exploration of Genetic and Epigenetic Effects on Brain Gray Matter in Schizophrenia

Association Between Schizophrenia and DNA Demethylase Activity in Human Peripheral Blood Mononuclear Cells

Large-scale analysis of DNA methylation identifies cellular alterations in blood from psychosis patients and molecular biomarkers of treatment-resistant schizophrenia